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1 Introduction
Pleural effusion in a fetus is readily diagnosed
antenatally using ultrasound. It is well known that
fetuses with pleural effusion often die of respira-
tory failure during the neonatal period. We [8] also
reported previously that the outcome of fetuses
with nonimmunologic hydrops fetalis (NIHF)
complicated further by pleural effusion was sig-
nificantly poor, compared to that in NIHF with-
out pleural effusion, and suggested that the cause
of death in fetuses with pleural effusion may be
associated with hypoplastic lung.
The possible relation of the cause and effect be-
tween pleural effusion and hypoplastic lung, how-
ever, remained unclear. The influence of pleural
effusion on pulmonary growth in affected fetuses
had to be clarified in order to establish proper
perinatal management.
In the present study, we attempted to assess the
correlation between lung weight and the time of
initial diagnosis or the duration of presence of
pleural effusion, in order to clarify the influence
of pleural effusion on pulmonary growth in the
human fetus.
2 Materials and methods
Thirty-three fetuses with pleural effusion were di-
agnosed antenatally, at the Maternity Care Unit
of Kyushu University Hospital between January
1983 and March 1988. In 20 out of 33 cases,
autopsies were performed and lung weights were
measured, the results of which make up this study.
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Of the remaining 13 cases, 9 were excluded because
of the family's refusal to allow an autopsy and the
last 4 cases diagnosed after 30 weeks of gestation
survived through to the time of this writing. Drain-
age of pleural effusion, on a continuous basis,
from the thoracic cage in utero, was not performed
on any of these cases.
Wet weight measured at autopsy was used as the
weight for each organ. In order to evaluate pul-
monary growth, the lung weight/body weight ratio
and the standard deviation from the mean normal
weight at each gestational age was used [5, 7]. The
normal standard of body and organ weights used
was that reported by GRUENWALD et al [3].
Information concerning the time of initial diag-
nosis and delivery, along with the findings at au-
topsy, were obtained from medical records kept in
our hospital.
Statistical analysis was performed using the chi-
square test, and a p-value of less than 0.05 was
regarded as being statistically significant.
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3 Results
Underlying diseases and lung weights of the
twenty cases studied are shown in table I.
Gestational age at the time of initial diagnosis
ranged from 21 to 35 weeks, and the time of
delivery ranged from 23 to 36 weeks of gestation.
The time between the initial diagnosis and delivery
ranged in duration from 5 days to 8 weeks.
Lung weights ranged from 1.8 to 33.0 grams, and
the lung weight/body weight ratio was less than
0.020 [5, 7] in all cases. The distribution of the
standard deviation from the mean weight for the
body, heart, liver and lungs is shown in figure 1.
Body weights were within the mean ± 1.5 S. D. in
11 of 20 cases, more than +1.5 S.D. in eight
cases and less than —1.5 S. D. in one case. Heart
weights were within the mean + 1.5 S. D. in 16 of
20 cases, more than + 1.5 S.D. in two cases and
less than —1.5 S.D. in two cases. Liver weights
were within the mean + 1.5 S. D. in 17 of 20 cases
and less than —1.5 S.D. in three cases. Lung
weights were within the mean ± 1.5 S. D. in eight
of 20 cases, and less than —1.5 S.D. in 12 cases.
The rate of incidence of cases with weights less
than —1.5 S.D. in body, heart, liver and lungs is
5.0%, 10.0%, 15.0% and 60.0%, respectively. The
incidence of cases with lung weights less than —1.5
S. D. was significantly higher than the incidence
of cases with weights of less than —1.5 S. D. for
other organs in cases with pleural effusion
(p < 0.01).
-2.0SD -1.5SD MEAN +1.5SD +2.0SD
Weight
Figure 1. Body and organs weights in 20 cases affected
with NIHF with pleural effusion. Weights are expressed
in the form of the standard deviation from the mean
weight at each gestational age.
Table I. Underlying diseases and lung weights of 20 cases with pleural effusion
Underlying disease
Coarctation of the aorta
T/F* + ASD**
Premature closure of foramen ovale
Hypertrophy of bilateral ventricles
Nuchal hygroma
Cystic adenomatoid malformation of the lung
Trisomy 21
Human Parvo virus B-19 infection
Idiopathic hydrops fetalis
No. of
cases
1
1
1
1
1
2
2
3
8
Mean
± 1.5 SD
1
1
1
1
4
Lung Weight
< -1.5 SD
1
1
2
1
< -2.0 SD
1
1
1
4
Total 20
*T/F: tetralogy of Fallot, **ASD: Atrial septal defect
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The correlation between the time of initial diag-
nosis and lung weight is shown in figure 2. In all
the cases with lung weights of less than —2.0 S. D.,
pleural effusion was diagnosed during the first 29
weeks of gestation. However, when the incidence
of lung weights of less than —1.5 S.D. or —2.0
S. D. was compared by gestational age from 22 to
34 weeks, there were no statistical significant dif-
ferences.
With regard to the correlation between the dura-
tion of the presence of pleural effusion and lung
weight, the shortest duration showing a statisti-
cally significant difference obtained in the inci-
dence of lung weights of less than —1.5 S. D. or
— 2.0 S.D., was two weeks. In six cases with a
duration of less than two weeks, lung weights were
within the mean ±1.5 S.D. On the contrary, in
14 cases having a duration of more than two
weeks, lung weights were less than —1.5 S.D. in
12 cases (85.7%), and less than -2.0 S. D. in seven
cases (50.0%) (figure 3). The incidence of cases
with lung weights of less than —1.5 S.D. or —2.0
S.D. significantly increased in situations where the
duration of pleural effusion was more than two
weeks, compared to those cases in which the du-
ration was less than two weeks (p < 0.01,
p < 0.05, respectively).
Weight
+ 2.0SD Γ
+ 1.5SD
4 Discussion
Pleural effusion in a fetus, theoretically, can inhibit
pulmonary growth by increasing intrathoracic
pressure. However, the relation of cause and effect
between persistent pleural effusion and the devel-
opment of hypoplastic lung has not been proven
in human subjects.
CASTILLO et al [1], and SHIMOKAWA et al [9] re-
ported that the outcome of nonimmunologic hy-
drops fetalis (NIHF) with pleural effusion is sig-
nificantly poor, compared to that of NIHF with-
out pleural effusion, and suggested that the cause
of death may be associated with the coexistence
of hypoplastic lung. CASTILLO et al [2] reported
that normal lung development was disturbed in 9
cases of NIHF with pleural effusion, using histo-
logical examination. In the present study, 12 of 20
cases had lung weights of less than —1.5 S. D. and
7 cases had lung weights of less than —2.0 S.D.
This evidence indicates that persistent pleural ef-
fusion often coexists with the inhibition of pul-
monary growth in the fetus, irrespective of under-
lying diseases the fetus may have.
With regard to the definition of hypoplastic lung,
REALE et al [7] proposed a lung weight/body
weight ratio of less than 0.020 as an indicator.
MEAN
-1.5SD
-2.0SD
-3.0SD
Figure 2. The correlation between the time of initial diagnosis and lung weight. Weights are expressed in the form
of the standard deviation from the mean weight at each gestational age.
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Figure 3. The correlation between the duration of the
presence of pleural effusion and lung weight. Weights
are expressed in the form of the standard deviation from
the mean weight at each gestational age.
NIMROD et al [5] proposed both a lung weight/
body weight ratio of less than 0.020 and a lung
weight of less than —2.0 S.D. as the indicator of
hypoplastic lung. For evaluating the hypoplastic
lung in NIHF, the criteria of NIMROD et al [5]
seems to be better than that of REALE et al [7],
because body weight in NIHF may be heavy due
to the accumulation of ascites or pleural effusion.
In the present study, the lung weight/body weight
ratio was less than 0.020 in all cases, but lung
weights of less than —2.0 S. D. were found in only
seven of 20 cases. These results indicate that a
fetus with pleural effusion does not always have
hypoplastic lung. In this study, all seven cases with
hypoplastic lung as defined by the criteria of NIM-
ROD et al [5] had a duration of persistent pleural
effusion of more than two weeks. On the contrary,
in the six cases, with a duration of less than two
weeks, lung weights were within the mean ±1.5
S.D. This fact suggests that pulmonary growth
may not be inhibited if the duration of persistent
pleural effusion is less than two weeks, and indi-
cates that the development of pulmonary hypo-
plasia in a fetus with pleural effusion depends on
the duration of the pleural effusion.
In addition, the time of onset of pleural effusion
may also influences pulmonary growth in the fe-
tus. The structural development of the human fetal
lung has been divided into the following four
stages [4]; 1) the embryonic stage, 2) the pseudog-
landular stage, 3) the canalicular stage and 4) the
alveolar stage. The earlier the gestational age at
the onset of pleural effusion, the stronger the
influence on pulmonary development may be.
CASTILLO et al [2] suggested that significant fluid ;
accumulation in the pleural space prior to the
alveolar stage could cause inevitable damage to
the developing lung in a fetus. NIMROD et al [6]
reported that, in fetuses with premature rupture
of membrane, the risk of developing pulmonary
hypoplasia was significantly higher in fetuses with
rupture of membranes before 26 weeks of gesta-
tion, compared to that of fetuses with a rupture
of membrane after 26 weeks of gestation. Al-
though, in the present study, the time of onset of
pleural effusion could not be diagnosed accurately,
the time of diagnosis was before 29 weeks of
gestation in all the cases with lung weights of less
than -2.0 S.D. With regard to the relation be-
tween time of diagnosis and lung weight, however,
there was no statistical significant difference in the
incidence of lung weights of less than —1.5 S. D.
or —2.0 S.D. among the gestational age groups
divided by one-week intervals, ranging from 22 to
34 weeks. Further investigation is necessary to
clarify the correlation between the time of onset
of pleural effusion and the development of pul-
monary hypoplasia.
In conclusion, the findings indicate that persistent
pleural effusion in a fetus can inhibit pulmonary
growth, and that the development of hypoplastic
lung in fetuses with pleural effusion depends on
the length of the presence of pleural effusion. In
addition, the results also suggest that pulmonary
growth may not be influenced by persistent pleural
effusion of less than two weeks. Therefore, pul-
monary hypoplasia in a fetus with pleural effusion
may be prevented by continuous removal of
pleural effusion using an effective drain in utero.
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Abstract
The present study was performed to clarify the relation
of cause and effect between pleural effusion and hypo-
plastic lung in the human fetus. In six cases with a
duration of less than two weeks between the initial
diagnosis of pleural effusion and delivery, lung weights
were within the mean weight ± 1.5 S.D. In fourteen
cases with a duration of more than two weeks between
diagnosis and delivery, seven cases had lungs with
weights of less than — 2.0 S. D. and twelve had lungs of
Keywords: Fetus, hypoplastic lung, pleural effusion.
less than —1.5 S.D. in weight. The incidence of lung
weights less than —1.5 S.D. or —2.0 S.D. was signifi-
cantly higher in cases with a diagnosis-delivery duration
of more than two weeks, compared to those with a
duration of less than two weeks. These results suggest
that the development of hypoplastic lung in fetuses with
pleural effusion may depend on the length of the pres-
ence of pleural effusion.
Zusammenfassung
Einfluß eines Pleuraergusses auf das Lungenwachstum
beim menschlichen Feten
Um den Einfluß eines Pleuraergusses auf das Lungen-
wachstum beim menschlichen Feten zu erfassen, ver-
suchten wir in der vorliegenden Studie die Korrelation
zwischen dem fetalen Lungengewicht und dem Auftreten
bzw. der Dauer eines Pleuraergusses zu bestimmen. Bei
20 Feten mit einem pränatal diagnostizierten Pleuraer-
guß wurden Autopsien durchgeführt und die Lungen-
gewichte gemessen. Sie lagen zwischen 1.8 und 33.0
Gramm. Die Ratio Lungengewicht/Körpergewicht war
in allen Fällen < 0.020. Im Hinblick auf eine Korrelation
zwischen der Erstdiagnose eines Pleuraergusses und dem
Lungengewicht fanden wir folgendes: zwischen 22 und
34 Gestationswochen kommen Lungengewichte von
mehr als 1.5 oder 2.0 Standardabweichungen unterhalb
des Mittels statistisch gleich häufig vor. Nimmt man
jedoch die Dauer eines Pleuraergusses und korreliert sie
mit dem Lungengewicht, so ergibt sich folgendes Bild:
in 6 Fällen, wo der Erguß weniger als zwei Wochen
bestand, lagen die Lungengewichte innerhalb von ±1.5
Standardabweichungen. Bestand der Erguß jedoch län-
ger als zwei Wochen, wie in 14 Fällen, so lagen in 12
Fällen (85,7%) die Lungengewichte um 1.5 Standardab-
weichungen und in 7 Fällen (50.0%) um 2.0 Standar-
dabweichungen unter dem Mittel. Die Inzidenz von Lun-
gengewichten von mehr als 1.5 oder 2.0 Standardabwei-
chungen unterhalb des statistischen Mittels nahm also
in den Fällen, wo der Pleuraerguß länger als zwei Wo-
chen bestand, signifikant gegenüber den Fällen zu, wo
der Erguß weniger als zwei Wochen vorlag (p < 0.01
bzw. p < 0.05). Diese Ergebnisse weisen darauf hin, daß
ein persistirender Pleuraerguß das Lungenwachstum
hemmen kann und daß die Entwicklung von hypopla-
stischen Lungen bei Feten mit Pleuraerguß abhängig ist
von der Dauer des Ergusses. Auf der anderen Seite
scheint ein Pleuraerguß, der weniger als zwei Wochen
besteht, das Lungenwachstum nicht zu beeinflussen.
Schlüsselwörter: Fet, hypoplastische Lungen, Pleuraerguß.
Resume
Influence de l'epanchement pleural sur la croissance pul-
monaire chez le foetus humain
Dans cette etude, afin de clarifier Finfluence de Pepan-
chement pleural sur la croissance pulmonaire chez le
foetus humain, nous avons essaye d'estimer la correlation
entre le poids pulmonaire foetal et le moment du dia-
gnostic initial d'epanchement pleural ou la duree de
l'existence de Fepanchement pleural. Nous avons realise
des autopsies avec determination des poids des poumons
chez 20 foetus chez lesquels le diagnostic d'epanchement
pleural avait etc porte en prenatal. Les poids des pou-
mons vont de 1,8 ä 33 grammes et le ratio poids pul-
monaire/poids corporel est inferieur ä 0,020 dans tous
les cas. Nous n'avons pas trouve de difference statisti-
quement significative en ce qui concerne la correlation
entre' le moment du diagnostic initial et le poids pul-
monaire, si Fincidence des poids pulmonaires inferieurs
ä —1,5 DS ou — 2 DS est rapporte a Tage gestationnel
de 22 a 34 semaines. Neanmoins, en ce qui concerne la
correlation entre les poids pulmonaires et la duree de la
presence de Fepanchement pleural, les poids pulmonaires
se situaient dans la moyenne + ou —1,5 DS, dans six
cas avec une duree de moins de 2 semaines. A Finverse,
dans 14 cas avec une duree de plus de 2 semaines, les
poids pulmonaires etaient inferieurs a —1,5 DS, dans
12 cas (85,7%) et inferieurs ä -2 DS dans 7 cas (50%).
Uincidence des cas avec poids pulmonaires inferieurs ä
— 1,5 DS ou — 2DS est significativement augmentee
dans les situations ou on a trouve que la duree de
Fepanchement pleural etait superieure a 2 semaines, par
rapport aux cas pour lesquels la duree de Fepanchement
pleural etait inferieur ä 2 semaines (respectivement
p < 0,01, p < 0,05). Ces donnees indiquent que la per-
sistance d'un epanchement pleural peut inhiber la crois-
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236 Maeda et al., Pleural effusion and pulmonary growth
sance pulmonaire et aue Papparition d'une hypoplasie
pulmonaire chez les foetus porteurs d'un epanchement
pleural depend de la duree de la presence de 1'epanche-
ment. En outre, les resultats suggerent egalement que la
croissance pulmonaire peut ne pas etre influencee par
un epanchement pleural de moins de deux semaines.
Mots-cles: Epanchement pleural, foetus, poumon hypoplasique.
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